Cabaletta Bio, Inc. ( CABA) - Key Metrics
CABA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | -$0.44 | -$0.34 | -$0.34 |
| 2025Q2 | ? | -$0.73 | -$0.49 | -$0.49 |
| 2025Q1 | ? | -$0.73 | -$0.62 | -$0.64 |
CABA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -1.33 |
| 2025Q2 | ? | -0.52 |
| 2025Q1 | ? | -0.48 |
CABA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -14.12% | ? |
| 2025Q4 | -15.87% | ? |
| 2025Q3 | -14.45% | ? |
| 2025Q2 | -32.52% | ? |
| 2025Q1 | -45.89% | ? |
CABA
Price: $3.25
52 week price:
Earnings Per Share: -1.78 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 489500
Market Capitalization: 635.1 million